SQUIRE PATTON BOGGS for RANBAXY INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Prescription Drug User Fee Reauthorization issues; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Foreign entity interest: Ranbaxy Labs Limited - Interests are same as Registrant.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN JONAS | — |
| CAITLIN SUZANNE MCCORMICK New | — |
| MATTHEW TODD TUTEN | RepMichaelBilirakis91-92;93-95;98-01 |
| ANURAG VARMA | — |
Pharmacy PHA
S. 214, Preserve Access to Affordable Generics; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act; Prescription Drug User Fee Reauthorization issues; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Foreign entity interest: Ranbaxy Labs Limited - Interests are same as Registrant.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN JONAS | — |
| CAITLIN SUZANNE MCCORMICK New | — |
| MATTHEW TODD TUTEN | RepMichaelBilirakis91-92;93-95;98-01 |
| ANURAG VARMA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.